• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The effect of biocompatible peritoneal dialysis solutions on neutrophil to lymphocyte ratio.

作者信息

İnal Salih, Okyay Gülay Ulusal, Ulu Memnune Sena, Kıdır Veysel, Altuntaş Atila, Ahsen Ahmet, Ünverdi Selman, Akoğlu Hadim, Yüksel Şeref, Duranay Murat, Sezer Mehmet Tuğrul

机构信息

Department of Internal Medicine, Division of Nephrology, Süleyman Demirel University Medical School , Isparta , Turkey .

出版信息

Ren Fail. 2014 Sep;36(8):1239-43. doi: 10.3109/0886022X.2014.937662. Epub 2014 Jul 10.

DOI:10.3109/0886022X.2014.937662
PMID:25009984
Abstract

INTRODUCTION

Long-term exposure to dialysis solutions is an important contributor to the ongoing inflammatory process in peritoneal dialysis (PD) patients. Some studies have shown amelioration of this adverse effect with biocompatible solutions. We aimed to compare the neutrophil-to-lymphocyte (N/L) ratio in PD patients using biocompatible and standard solutions and to find out the association between N/L ratio and peritonitis indices.

MATERIALS AND METHODS

This was a cross-sectional, multicenter study involving 120 prevalent PD patients. Seventy-one patients (59%) were using biocompatible solutions and 49 patients (41%) were using standard solutions. From blood samples, N/L ratio and platelet-to-lymphocyte ratio were calculated and mean platelet volume, erythrocyte sedimentation rate and hs-CRP values were detected. Data regarding the peritonitis rate and time to first peritonitis episode were also recorded.

RESULTS

Biocompatible and standard groups were similar regarding age and gender. N/L ratio and hs-CRP levels have been found significantly higher in patients using biocompatible solutions (3.75 ± 1.50 vs. 3.27 ± 1.3, p = 0.04 and 3.2 ± 2.5 vs. 1.8 ± 2.0, p < 0.01, respectively). Peritonitis rates and time to the first peritonitis episode were found similar in patients using both types of solutions (0.23 ± 0.35 vs. 0.27 ± 0.32, p = 0.36 and 32.8 ± 35.8 vs. 21.5 ± 26.9 months, p = 0.16, respectively).

DISCUSSION

N/L ratio was significantly higher in biocompatible solution users in parallel to hs-CRP levels, so biocompatible solutions seem to be related with increased inflammation in PD patients. Although we cannot make a certain explanation, we assume that there may be an association between acidity of the peritoneal content and virulence of microorganisms.

摘要

相似文献

1
The effect of biocompatible peritoneal dialysis solutions on neutrophil to lymphocyte ratio.
Ren Fail. 2014 Sep;36(8):1239-43. doi: 10.3109/0886022X.2014.937662. Epub 2014 Jul 10.
2
Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial.中性 pH、低葡萄糖降解产物腹膜透析液与标准液的经济学评价:BALANZ 试验的二次分析。
Am J Kidney Dis. 2015 May;65(5):773-9. doi: 10.1053/j.ajkd.2014.12.017. Epub 2015 Mar 4.
3
The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.生物相容性碳酸氢盐腹膜透析液条件下透析液中癌抗原125浓度的变化及间皮细胞活力的维持。
Ren Fail. 2008;30(2):161-7. doi: 10.1080/08860220701808384.
4
Effects of conventional versus biocompatible peritoneal dialysis solutions on peritoneal and systemic inflammation, malnutrition and atherosclerosis in CAPD patients.传统腹膜透析液与生物相容性腹膜透析液对持续性非卧床腹膜透析患者腹膜和全身炎症、营养不良及动脉粥样硬化的影响。
Clin Nephrol. 2011 Oct;76(4):314-22. doi: 10.5414/cn106991.
5
A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.生物相容性腹膜透析液与残余肾功能、腹膜转运及炎症标志物的联合应用:一项随机临床试验。
Am J Kidney Dis. 2012 Dec;60(6):966-75. doi: 10.1053/j.ajkd.2012.05.018. Epub 2012 Jul 25.
6
Peritoneal cells at admission: do they have prognostic significance in peritonitis?入院时的腹膜细胞:它们在腹膜炎中有预后意义吗?
Ren Fail. 2010 Jan;32(3):335-42. doi: 10.3109/08860221003611679.
7
Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes.生物相容性腹膜透析液与腹膜炎风险、治疗和结局的关系。
Clin J Am Soc Nephrol. 2013 Sep;8(9):1556-63. doi: 10.2215/CJN.12361212. Epub 2013 Aug 15.
8
Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.新腹膜透析患者全身和局部腹膜炎症对腹膜溶质转运率的影响:一项为期 1 年的前瞻性研究。
Nephrol Dial Transplant. 2010 Jun;25(6):1964-73. doi: 10.1093/ndt/gfp767. Epub 2010 Jan 25.
9
Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis.透析液细胞计数在并发于腹膜透析的腹膜炎中的预测价值。
Clin J Am Soc Nephrol. 2006 Jul;1(4):768-73. doi: 10.2215/CJN.01010306. Epub 2006 May 31.
10
Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function.生物相容性腹膜透析液的随机对照研究:对残余肾功能的影响
Kidney Int. 2008 Jan;73(2):200-6. doi: 10.1038/sj.ki.5002574. Epub 2007 Oct 3.